Trial Profile
Effect of rituximab extended therapy in older patients with Non-Hodgkin Lymphoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 12 May 2015 New trial record